Therefore, FLC-k can be used as a marker for not only IgG dominant inflammatory diseases like MS, but also for IgM- (e.g., neuroborreliosis) or IgA-dominant diseases (e.g., neurotuberculosis). This evidence concerns the gene CD79A and myeloid sarcoma.